ZA852194B - Immunosuppressant factor - Google Patents

Immunosuppressant factor

Info

Publication number
ZA852194B
ZA852194B ZA852194A ZA852194A ZA852194B ZA 852194 B ZA852194 B ZA 852194B ZA 852194 A ZA852194 A ZA 852194A ZA 852194 A ZA852194 A ZA 852194A ZA 852194 B ZA852194 B ZA 852194B
Authority
ZA
South Africa
Prior art keywords
factor
immunosuppressant
immunosuppressant factor
interleukin
exhibits
Prior art date
Application number
ZA852194A
Other languages
English (en)
Inventor
Adriano Fontana
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP84810140A external-priority patent/EP0155433A1/fr
Priority claimed from GB848429679A external-priority patent/GB8429679D0/en
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA852194B publication Critical patent/ZA852194B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Glass Compositions (AREA)
ZA852194A 1984-03-23 1985-03-22 Immunosuppressant factor ZA852194B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP84810140A EP0155433A1 (fr) 1984-03-23 1984-03-23 Facteur immunosuppresseur
GB848429679A GB8429679D0 (en) 1984-11-23 1984-11-23 Immunosuppressant factor

Publications (1)

Publication Number Publication Date
ZA852194B true ZA852194B (en) 1986-11-26

Family

ID=26095665

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA852194A ZA852194B (en) 1984-03-23 1985-03-22 Immunosuppressant factor

Country Status (12)

Country Link
EP (1) EP0159289B1 (fr)
JP (1) JPH0680080B2 (fr)
AT (1) ATE75778T1 (fr)
AU (1) AU587973B2 (fr)
CA (1) CA1341401C (fr)
DE (1) DE3585968D1 (fr)
DK (1) DK171600B1 (fr)
IE (1) IE58821B1 (fr)
IL (1) IL74680A (fr)
NZ (1) NZ211525A (fr)
WO (1) WO1985004421A1 (fr)
ZA (1) ZA852194B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342614A (en) * 1984-12-21 1994-08-30 Otsuka Pharmaceutical Co., Ltd. Method of treating arthritus or inflammation with IL-1β or derivatives thereof
US6107465A (en) * 1984-12-21 2000-08-22 Otsuka Pharmaceutical Co., Ltd. IL-1β and derivatives thereof and drugs
DK172052B1 (da) * 1984-12-21 1997-09-29 Otsuka Pharma Co Ltd Antitumor-aktivt stof, fremgangsmåde til dets fremstilling, lægemiddel indeholdende stoffet, gen kodende for stoffet, vektor indeholdende genet samt rekombinant mikroorganisme transformet med en sådan vektor
US4886747A (en) * 1985-03-22 1989-12-12 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
US5284763A (en) * 1985-03-22 1994-02-08 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
US6586394B1 (en) 1985-04-19 2003-07-01 Osi Pharmaceuticals, Inc. Tissue-derived tumor growth inhibitor
US5008374A (en) * 1986-03-14 1991-04-16 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and drugs
JPS63126897A (ja) * 1986-05-02 1988-05-30 Yoshitomi Pharmaceut Ind Ltd 免疫抑制因子
EP0268561A3 (fr) * 1986-11-17 1988-10-26 Sandoz Ag Préparation et utilisation d'un facteur suppresseur de cellules T
US5221620A (en) * 1987-10-06 1993-06-22 Oncogen Cloning and expression of transforming growth factor β2
US5250414A (en) * 1988-11-04 1993-10-05 Erziehungsdirektion Of The Canton Zurich Diagnostic methods using neurite growth regulatory factors
CA1341050C (fr) * 1988-11-04 2000-07-11 Martin E. Schwab Facteurs de regulations de la croissance des axones
DE68923362T2 (de) * 1988-11-04 1996-03-28 Zuerich Erziehungsdirektion Wachstumsregelfaktoren für neuriten.
WO1998046640A2 (fr) * 1997-04-15 1998-10-22 Coulter International Corp. Procedes et compositions permettant d'induire l'immunosuppression
WO2000031235A2 (fr) 1998-11-06 2000-06-02 Schwab Martin E Sequences nucleotidiques et proteiques de gene nogo et procedes reposant sur ces sequences
US6884413B1 (en) 1999-03-24 2005-04-26 The United States Of America As Represented By The Department Of Health And Human Services Induction of antigen-specific unresponsiveness by glioblastoma culture supernatants (GCS)
US7101543B2 (en) 2000-03-31 2006-09-05 Novarx Genetically modified cells expressing a TGFβ inhibitor, the cells being lung cancer cells

Also Published As

Publication number Publication date
DK171600B1 (da) 1997-02-17
WO1985004421A1 (fr) 1985-10-10
JPS61501514A (ja) 1986-07-24
AU587973B2 (en) 1989-09-07
DK539285D0 (da) 1985-11-21
CA1341401C (fr) 2002-11-26
NZ211525A (en) 1991-06-25
IE58821B1 (en) 1993-11-17
AU4157685A (en) 1985-11-01
EP0159289B1 (fr) 1992-05-06
ATE75778T1 (de) 1992-05-15
IE850732L (en) 1985-09-23
EP0159289A1 (fr) 1985-10-23
JPH0680080B2 (ja) 1994-10-12
DE3585968D1 (de) 1992-06-11
DK539285A (da) 1985-11-21
IL74680A (en) 1988-11-30
IL74680A0 (en) 1985-06-30

Similar Documents

Publication Publication Date Title
IL74680A (en) Immunosuppressant factor derived from human glioblastoma cells
DE3869184D1 (de) Festelektrolyt-brennstoffzelle und zusammenbau.
GB2203138B (en) Shaped wood-based active carbon
DE3574579D1 (en) Platte.
JPS6460373A (en) Human cells and trioner, antibody and trasformer derived from said cells
NO167240C (no) Feste med flere frihetsgrader.
NO167122C (no) Implanterbar kneprotese.
DE3578806D1 (de) Hueftimplantat.
EP0206424A3 (en) R.f. power amplifier
IT209301Z2 (it) Protesi uditiva.
IL87001A0 (en) Haloarylnitrile degrading gene,and cells containing the gene
GR3017451T3 (en) Peptides having T cell helper activity.
EP0215067A4 (fr) Un regulateur de fonction reglable, pouvant etre realise au cabinet dentaire.
DE3888640D1 (de) Stromregler.
DE68917283D1 (de) Gasdichte Blei-Säure-Batterie.
GR851617B (fr)
DE3673217D1 (de) Phenylalkyl-2,3-dihydrobenzofurane und analoga zur verwendung als antientzuendungsmittel.
DE69102115D1 (de) Bipolare Batterie und Zusammenbau-Methode.
EP0282501A4 (fr) Regulation de la reproduction animale.
DE3676632D1 (de) 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thione und ihre verwendung als antidepressiva.
NO851398L (no) Taakeleggingslegeme.
DE3680885D1 (de) 5-heterocyclisch substituierte-3h-1,2,4-triazol-3-thione und ihre verwendung als antidepressiva.
DE3877591D1 (en) Aminosaeure-derivate als antihypertensive.
ATE59385T1 (de) 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thione und ihre verwendung als antidepressiva.
SU1246568A1 (ru) 2`,2`,5,7-тетраметил-6-оксоспиро-(1,3-диазаадамантан- 2,4′ -тетрагидротиопиран), обладающий противостафилококковой активностью